Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of research funding models, in the context of the forthcoming national cancer plan; and whether he has made an assessment of the potential impact of research funding models on supporting (a) equitable, (b) clinical and (c) economic opportunities.

The Department is committed to ensuring that all patients, including those with cancer, have access to cutting-edge clinical trials and innovative, lifesaving treatments.

The Department is committed to turbocharging clinical research and delivering better patient care, to make the United Kingdom a world-leading destination for clinical research. We are working to fast-track clinical trials to drive global investment into life sciences, improve health outcomes, and accelerate the development of the medicines and therapies of the future, including treatments for cancer.

The Department funded National Institute for Health and Care Research (NIHR) funds research and research infrastructure which supports patients and the public to participate in high-quality research, including research on cancer. The NIHR also provides an online service called Be Part of Research, which promotes participation in health and social care research by allowing users to search for relevant studies and register their interest. This makes it easier for people to find and take part in health and care research that is relevant to them, including cancer studies.

Research is crucial in tackling cancer, which is why the Department invests over £1.6 billion per year in health research through the NIHR. The NIHR spent £133 million on cancer research in 2023/24, reflecting its high priority. The National Cancer Plan, due to be published in the second half of this year, will have a focus on research and innovation. It will include details on how we will improve outcomes for cancer patients, as well as speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately driving up this country’s cancer survival rates.